Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Long-Term-Liabilities" stands at 746.10 Billion Japanese Yens as of 06/30/2025.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Total Long Term Liabilities" stands at 746.10 Billion JPY. This represents a decrease of -2.43 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.88 percent compared to the value the year prior.
The 1 year change in percent is 8.88.
The 3 year change in percent is 268.90.
The 5 year change in percent is 147.32.
The 10 year change in percent is 1,257.00.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Liabilities | 280,205,508,085.11 |